RCT | Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity.

Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity (MERIT): a prospective, multicentre, randomised trial – The Lancet (link to abstract – $ for full-text)

Commentary on Twitter

MERIT trial suggests endoscopic sleeve gastroplasty should be considered as a synergistic weight loss intervention for patients with class 1 or class 2 obesity.

Find out more: https://t.co/FWeXeWbBF0 pic.twitter.com/W6qUKW92hR

— The Lancet (@TheLancet) July 30, 2022